These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 7709892)

  • 21. Heart lines. Revised cholesterol guidelines.
    Harv Heart Lett; 2001 Jul; 11(11):6-7. PubMed ID: 11512536
    [No Abstract]   [Full Text] [Related]  

  • 22. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
    Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
    Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cholesterol absorption as a target for the treatment of hypercholesterolemia].
    Bitzur R; Cohen H; Harats D
    Harefuah; 2006 Nov; 145(11):831-5, 861, 860. PubMed ID: 17183957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of hypercholesterolemia in a family practice setting.
    Levin SJ; Ornstein SM
    J Fam Pract; 1990 Dec; 31(6):613-7. PubMed ID: 2246635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrocardiographic events and cholesterol reduction with pravastatin in patients with hypercholesterolemia: the Hokuriku Lipid Coronary Heart Disease Study-Pravastatin Atherosclerosis Trial.
    Shimizu M; Koizumi J; Miyamoto S; Origasa H; Mabuchi H;
    Int J Cardiol; 2005 Mar; 99(3):395-401. PubMed ID: 15771919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure].
    Stalenhoef AF
    Ned Tijdschr Geneeskd; 2006 Sep; 150(39):2127-30. PubMed ID: 17059084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cholesterol and coronary heart disease: screening and treatment.
    Turner-Boutle M
    Nurs Times; 1998 Apr 15-21; 94(15):46-7. PubMed ID: 9615661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving cholesterol control in managed care populations.
    McKenney JM
    Am J Manag Care; 2000 Nov; 6(19 Suppl):S997-1007. PubMed ID: 11187371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low density lipoprotein cholesterol lowering: are the treatment guidelines still appropriate?
    Deslypere JP
    Int J Clin Pract; 2000 Jun; 54(5):307-13. PubMed ID: 10954957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypercholesterolemia. Is lipid-lowering worthwhile for older patients?
    Deedwania PC
    Geriatrics; 2000 May; 55(5):22-8. PubMed ID: 10826262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A survey on the status of lipid-lowering therapy in 180 hypercholesterolemic patients].
    Cai S; Xia S; Xie H; Yao X; Wang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Oct; 23(5):378-81; discussion 381-2. PubMed ID: 12482372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Statins in secondary prevention of coronary heart disease].
    Sandhofer F
    Wien Med Wochenschr; 1999; 149(5-6):125-8. PubMed ID: 10408003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol management.
    Griffith K
    Practitioner; 2006 Sep; 250(1686):23-4, 26, 29. PubMed ID: 17036915
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of hypercholesterolemia in patients undergoing multiple coronary angioplasties.
    Marques V; Bowser S; Hendrickxs J; Ruffner R
    Rev Port Cardiol; 1996 Nov; 15(11):787-91, 771-2. PubMed ID: 8993109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of mortality from coronary heart disease with pravastatin.
    Tonkin AM; Ryan EW
    Biomed Pharmacother; 1999 Oct; 53(9):405-8. PubMed ID: 10554675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cholesterol-lowering therapy; a recommendation from the Health Council].
    Simoons ML
    Ned Tijdschr Geneeskd; 2000 Dec; 144(51):2442-4. PubMed ID: 11151651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein Lp(a) excess and coronary heart disease.
    Stein JH; Rosenson RS
    Arch Intern Med; 1997 Jun; 157(11):1170-6. PubMed ID: 9183227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In whom, when and how should increased cholesterol values be treated?].
    Greten H
    Arzneimittelforschung; 1990 Mar; 40(3A):381-3. PubMed ID: 2185770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measuring cholesterol levels.
    Pottle A
    Nurs Stand; 2007 Jul 25-31; 21(46):42-7. PubMed ID: 17711246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.